A multicenter randomized trial comparing rabeprazole and itopride with functional dyspepsia in Japan: the NAGOYA study

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2014
INTERVENTION: rabeprazole group itopride group CONDITION: Functional dyspepsia PRIMARY OUTCOME: Change Rates in dyspepsia scores (FD scores) between pretreatment (100%) and each time‐point SECONDARY OUTCOME: sub‐analysis in FD scores of epigastric pain syndrome (EPS) and postprandial distress syndrome (PDS) based on the Rome III criteria INCLUSION CRITERIA: Functional dyspepsia patients, in whom organic disease underwent upper endoscopy had been excluded, who met the Rome III criteria
Epistemonikos ID: 57cb76df44c05e32fe64cd7c0df7d37cf82a593a
First added on: Aug 22, 2024